References
- Acharya N., Penukonda S., Shcheglova T., Hagymasi A.T., Basu S., Srivastava P.K. (2017). Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc. Natl. Acad. Sci., USA, 114: 5005–5010.
- Basu S., Dittel B.N. (2011). Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunol. Res., 51: 26–38.
- Cabral G.A., Griffin-Thomas L. (2009). Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert. Rev. Mol. Med., 11: e3.
- Chiocchetti R., Bombardi C., Mongardi-Fantaguzzi C., Venturelli E., Russo D., Spadari A., Montoneri C., Romagnoli N., Grandis A. (2009). Intrinsic innervation of the horse ileum. Res. Vet. Sci., 87: 177–185.
- Cho Y.I., Yoon K.J. (2014). An overview of calf diarrhea – infectious etiology, diagnosis, and intervention. J. Vet. Sci., 15: 1–17.
- Cizkova K., Foltynkova T., Gachechiladze M., Tauber Z. (2021). Comparative analysis of immunohistochemical staining intensity determined by light microscopy, ImageJ and QuPath in placental Hofbauer cells. Acta Histochem. Cytochem., 54: 21–29.
- Cluny N.L., Baraboi E.D., Mackie K., Burdyga G., Richard D., Dock-ray G.J., Sharkey K.A. (2013). High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia. Auton Neurosci., 179: 122–130.
- Costa M., Brookes S., Hennig G. (2000). Anatomy and physiology of the enteric nervous system. Gut, 47: iv15–iv19.
- Crespillo A., Suárez J., Bermúdez-Silva F.J., Rivera P., Vida M., Alonso M., Palomino A., Lucena M.A., Serrano A., Pérez-Martín P., Macias M., Fernández-Llébrez P., Fonseca F.R. (2010). Expression of cannabinoid system in muscle: effects of high fat diet and CB1 receptor blockade. Biochem. J., 433: 175–185.
- De Petrocellis L., Melck D., Bisogno T., Milone A., Di Marzo V. (1999). Finding of the endocannabinoid signaling system in Hydra, a very primitive organism: Possible role in the feeding response. Neuroscience, 92: 377–387.
- Dhaka A., Uzzell V., Dubin A.E., Mathur J., Petrus M., Bandell M., Patapoutian A. (2009). TRPV1 is activated by both acidic and basic pH. J. Neurosci., 29: 153–158.
- DiPatrizio N.V. (2016). Endocannabinoids in the gut. Cannabis Cannabinoid Res., 1: 67–77.
- Duncan M., Davison J.S., Sharkey K.A. (2005). Review article: Endocannabinoids and their receptors in the enteric nervous system. Aliment. Pharmacol. Ther., 22: 667–683.
- Duncan M., Mouihate A., Mackie K., Keenan C.M., Buckley N.E., Davison J.S., Patel K.D., Pittman Q.J., Sharkey K.A. (2008). Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am. J. Physiol. Gastrointest. Liver Physiol., 295: G78–G87.
- Fernández-Carvajal A., Fernández-Ballester G., Ferrer-Montiel A. (2022). TRPV1 in chronic pruritus and pain: Soft modulation as a therapeutic strategy. Front. Mol. Neurosci., 15: 930964.
- Furness J.B. (2006). The enteric nervous system. Blackwell Publishing: Malden, MA, USA.
- Galiazzo G., Giancola F., Stanzani A., Fracassi F., Bernardini C., Forni M., Pietra M., Chiocchetti R. (2018). Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract. Histochem. Cell Biol., 150: 187–205.
- Henry B.M., Tomaszewski K.A., Walocha J.A. (2016). Methods of evidence-based anatomy: a guide to conducting systematic reviews and meta-analysis of anatomical studies. Ann. Anat., 205: 16–21.
- Hillard C.J. (2015). Endocannabinoids and the endocrine system in health and disease. In: Endocannabinoids, Pertwee R.G. (ed.). Springer Cham., Switzerland, pp. 317–339.
- Izzo A.A. (2004). Cannabinoids and intestinal motility: Welcome to CB2 receptors. Br. J. Pharmacol., 142: 1201–1202.
- Izzo A.A., Mascolo N., Pinto L., Capasso R., Capasso F. (1999). The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur. J. Pharmacol., 384: 37–42.
- Izzo A.A., Piscitelli F., Capasso R., Aviello G., Romano B., Borrelli F., Petrosino S., Di Marzo V. (2009). Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br. J. Pharmacol., 158: 451–461.
- Izzo A.A., Capasso R., Aviello G., Borrelli F., Romano B., Piscitelli F., Gallo L., Capasso F., Orlando P., Di Marzo V. (2012). Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br. J. Pharmacol., 166: 1444–1460.
- Janovick-Guretzky N.A., Dann H.N., Carlson D.B., Murphy M.R., Loor J.J., Drackley J.K. (2007). Housekeeping gene expression in bovine liver is affected by physiological state, feed intake, and dietary treatment. J. Dairy Sci., 90: 2246–2252.
- Kendall D.A., Yudowski G.A. (2016). Cannabinoid receptors in the central nervous system: their signaling and roles in disease. Front. Cell. Neurosci., 10: 294.
- Kono T., Kaneko A., Omiya Y., Ohbuchi K., Ohno N., Yamamoto M. (2013). Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine. Am. J. Physiol. Gastrointest. Liver Physiol., 304: G428– G436.
- Kunos G., Osei-Hyiaman D., Liu J., Godlewski G., Bátkai S. (2008). Endocannabinoids and the control of energy homeostasis. J. Biol. Chem., 283: 33021–33025.
- Lee J.Y., Lee G.J., Nakamura A., Lee P.R., Kim Y., Won C.H., Furue H., Oh S.B. (2020). Involvement of cannabinoid type 1 receptor in fasting-induced analgesia. Mol. Pain, 16: 1744806920969476.
- Livak K.J., Schmittgen T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods, 25: 402–408.
- Mackie K. (2006). Cannabinoid receptors as therapeutic targets. Ann. Rev. Pharmacol. Toxicol., 46: 101–122.
- Mazzuoli G., Mazzoni M., Albanese V., Clavenzani P., Lalatta-Costerbosa G., Lucchi M.L., Furness J.B., Chiocchetti R. (2007). Morphology and neurochemistry of descending and ascending myenteric plexus neurons of sheep ileum. Anat. Rec., 290: 1480–1491.
- Munro S., Thomas K.L., Abu-Shaar M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365: 61–65.
- Myers M.N., Zachut M., Tam J., Contreras G.A. (2021). A proposed modulatory role of the endocannabinoid system on adipose tissue metabolism and appetite in periparturient dairy cows. J. Anim. Sci. Biotechnol., 12: 21.
- Myers M.N., Abou-Rjeileh U., Chirivi M., Parales-Girón J., Lock A.L., Tam J., Zachut M., Contreras G.A. (2023). Cannabinoid-1 receptor activation modulates lipid mobilization and adipogenesis in the adipose tissue of dairy cows. J. Dairy Sci., 106: 3650–3661.
- O’Sullivan S.E. (2015). Endocannabinoids and the cardiovascular system in health and disease. Handb. Exp. Pharmacol., 231: 393–422.
- Pacher P., Bátkai S., Kunos G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 58: 389–462.
- Pertwee R.G. (2000). Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development. Exp. Opin. Investig. Drugs., 9: 1553–1571.
- Pertwee R.G. (2001). Cannabinoid receptors and pain. Prog. Neurobiol., 63: 569–611.
- Poonyachoti S., Kulkarni-Narla A., Brown D.R. (2002). Chemical coding of neurons expressing δ- and κ-opioid receptor and type I vanilloid receptor immunoreactivities in the porcine ileum. Cell Tissue Res., 307: 23–33.
- Silver R.J. (2019). The endocannabinoid system of animals. Animals, 9: 686.
- Skaper S.D., Di Marzo V. (2012). Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos. Trans. R. Soc. Lond. B Biol. Sci., 367: 3193–3200.
- Storr M.A., Keenan C.M., Zhang H., Patel K.D., Makriyannis A., Sharkey K.A. (2009). Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm. Bowel Dis., 15: 1678–1685.
- Tominaga M., Tominaga T. (2005). Structure and function of TRPV1. Pflug. Arch. Eur. J. Physiol., 451: 143–150.
- Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 21: 531–543.
- Toschi A., Galiazzo G., Piva A., Tagliavia C., Mazzuoli-Weber G., Chiocchetti R., Grilli E. (2021). Cannabinoid and cannabinoid-related receptors in the myenteric plexus of the porcine ileum. Animals, 11: 63.
- Turcotte C., Blanchet M.R., Laviolette M., Flamand N. (2016). The CB2 receptor and its role as a regulator of inflammation. Cell. Mol. Life Sci., 73: 4449–4470.
- Van Sickle M. D., Oland L.D., Ho W., Hillard C.J., Mackie K., Davison J.S., Sharkey K.S. (2001). Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology, 121: 767–774.
- Varghese F., Bukhari A.B., Malhotra R., De A. (2014). IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One, 9: e96801.
- Włodarczyk R., Budvytis M. (2011). Proper feeding of high-yielding cows – how to fulfill their productive potential (in Polish). Życie Weter., 86: 771–776.
- Wright K., Rooney N., Feeney M., Tate J., Robertson D., Welham M., Ward S. (2005). Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing, Gastroenterology, 129: 437–453.
- Wright K.L., Duncan M., Sharkey K.A. (2008). Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br. J. Pharmacol., 153: 263–270.
- Zwick M., Davis B.M., Woodbury C.J., Burkett J.N., Koerber H.R., Simpson J.F., Albers K.M. (2002). Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive, neurons in the mouse. J. Neurosci., 22: 4057–4065.